Developing vaccines against pathogenic bacteria based on synthetic glycans, Ben learned to apply his compounds in biological settings in vivo and in vitro. For his achievements, he received the Award for Excellence in Glycosciences and, in 2017, the prestigious Otto Hahn Medal by the Max Planck Society.
During his postdoctoral work in the lab of Carolyn R. Bertozzi at Stanford University as an Alexander von Humboldt foundation Feodor Lynen fellow, Ben developed an interest in “precision tools” to study glycosylation of human cells in great detail. He started as a Group Leader at the Crick and Imperial College London in 2018.
Towards the end of the show, Ben mentions a prize. Ben and colleagues from Imperial College and Stanford University were awarded the Royal Society of Chemistry’s new Chemistry Biology Interface Division Horizon Prize, the Rita and John Cornforth Award. More details on this can be found on the Francis Crick Institute’s website.